checkAd

    EQS-News  177  0 Kommentare Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER - Seite 3


     
    Neither the CSE nor its market regulator, as that term is defined in the policies of the CSE, accepts responsibility for the adequacy or accuracy of this release.


     

    06.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com

    Language: English
    Company: Defence Therapeutics Inc.
    1680 - 200 Burrard St
    V6C3L6 Vancouver
    Canada
    E-mail: info@defencetherapeutics.com
    Internet: https://defencetherapeutics.com
    ISIN: CA24463V1013
    WKN: A3CN14
    Listed: Regulated Unofficial Market in Frankfurt, Stuttgart; Toronto
    EQS News ID: 1649823

     
    End of News EQS News Service

    Lesen Sie auch

    1649823  06.06.2023 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1649823&application_name=news&site_id=wallstreet
    Seite 3 von 3



    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors


    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-News Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER - Seite 3 EQS-News: Defence Therapeutics Inc. / Key word(s): Miscellaneous Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER 06.06.2023 / 08:00 CET/CEST The issuer is solely responsible for the content of this …

    Artikel zu den Werten

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer